These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 27122792)

  • 1. Association between Plasma Fibrinogen Level and Saphenous Vein Graft Patency.
    Cersit S; Cay S; Koza Y; Acikgoz SK; Cabuk G; Senturk B; Dogan P
    Acta Cardiol Sin; 2014 May; 30(3):223-8. PubMed ID: 27122792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet distribution width and saphenous vein disease in patients after CABG. Association with graft occlusion.
    Ege MR; Guray U; Guray Y; Acıkgoz S; Demirkan B
    Herz; 2013 Mar; 38(2):197-201. PubMed ID: 22955688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radial artery grafts vs saphenous vein grafts in coronary artery bypass surgery: a randomized trial.
    Goldman S; Sethi GK; Holman W; Thai H; McFalls E; Ward HB; Kelly RF; Rhenman B; Tobler GH; Bakaeen FG; Huh J; Soltero E; Moursi M; Haime M; Crittenden M; Kasirajan V; Ratliff M; Pett S; Irimpen A; Gunnar W; Thomas D; Fremes S; Moritz T; Reda D; Harrison L; Wagner TH; Wang Y; Planting L; Miller M; Rodriguez Y; Juneman E; Morrison D; Pierce MK; Kreamer S; Shih MC; Lee K
    JAMA; 2011 Jan; 305(2):167-74. PubMed ID: 21224458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Ticagrelor Plus Aspirin, Ticagrelor Alone, or Aspirin Alone on Saphenous Vein Graft Patency 1 Year After Coronary Artery Bypass Grafting: A Randomized Clinical Trial.
    Zhao Q; Zhu Y; Xu Z; Cheng Z; Mei J; Chen X; Wang X
    JAMA; 2018 Apr; 319(16):1677-1686. PubMed ID: 29710164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Has the in situ right internal thoracic artery been overlooked? An angiographic study of the radial artery, internal thoracic arteries and saphenous vein graft patencies in symptomatic patients.
    Shah PJ; Bui K; Blackmore S; Gordon I; Hare DL; Fuller J; Seevanayagam S; Buxton BF
    Eur J Cardiothorac Surg; 2005 May; 27(5):870-5. PubMed ID: 15848328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Value of Inflammation Indexes in Predicting Patency of Saphenous Vein Grafts in Patients With Coronary Artery Bypass Graft Surgery.
    Aydın C; Engin M
    Cureus; 2021 Jul; 13(7):e16646. PubMed ID: 34462681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patency of the saphenous vein conduit anastomosed to the aortic dacron graft.
    Kara I; Koksal C; Boyacioglu K; Ay Y; Yanartas M; Metin Esen A
    J Cardiovasc Surg (Torino); 2013 Oct; 54(5):647-52. PubMed ID: 24002395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of graft patency 3 years after coronary artery bypass graft surgery. Department of Veterans Affairs Cooperative Study Group No. 297.
    Goldman S; Zadina K; Krasnicka B; Moritz T; Sethi G; Copeland J; Ovitt T; Henderson W
    J Am Coll Cardiol; 1997 Jun; 29(7):1563-8. PubMed ID: 9180120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prevention of early graft occlusion after coronary bypass grafting by post-operative reduction of plasma fibrinogen by H.E.L.P. apheresis. First evaluation of 12 patients treated during our study (44 bypasses)].
    Blessing F; Jaeger BR; Oberhoffer M; Reichart B; Seidel D
    Z Kardiol; 2003; 92(Suppl 3):III42-7. PubMed ID: 14663601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of lipoprotein(a) level with short- and long-term outcomes after CABG: The role of lipoprotein apheresis.
    Ezhov MV; Afanasieva OI; Il'ina LN; Safarova MS; Adamova IY; Matchin YG; Konovalov GA; Akchurin RS; Pokrovsky SN
    Atheroscler Suppl; 2017 Nov; 30():187-192. PubMed ID: 29096836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiographic predictors of 3-year patency of bypass grafts implanted on the right coronary artery system: a prospective randomized comparison of gastroepiploic artery, saphenous vein, and right internal thoracic artery grafts.
    Glineur D; D'hoore W; de Kerchove L; Noirhomme P; Price J; Hanet C; El Khoury G
    J Thorac Cardiovasc Surg; 2011 Nov; 142(5):980-8. PubMed ID: 22014339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term graft patency (3 years) after coronary artery surgery. Effects of aspirin: results of a VA Cooperative study.
    Goldman S; Copeland J; Moritz T; Henderson W; Zadina K; Ovitt T; Kern KB; Sethi G; Sharma GV; Khuri S
    Circulation; 1994 Mar; 89(3):1138-43. PubMed ID: 8124800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between plasma homocysteine levels and saphenous vein graft disease after coronary artery bypass grafts.
    Iwama Y; Mokuno H; Watanabe Y; Shimada K; Yokoi H; Daida H; Hosoda Y; Yamaguchi H
    Jpn Heart J; 2001 Sep; 42(5):553-62. PubMed ID: 11804297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of smoking and plasma factors on patency of femoropopliteal vein grafts.
    Wiseman S; Kenchington G; Dain R; Marshall CE; McCollum CN; Greenhalgh RM; Powell JT
    BMJ; 1989 Sep; 299(6700):643-6. PubMed ID: 2508847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term clinical outcome and graft patency of radial artery and saphenous vein grafts in multiple arterial revascularization.
    Ruttmann E; Dietl M; Feuchtner GM; Metzler B; Bonaros N; Taggart DP; Gaudino M; Ulmer H;
    J Thorac Cardiovasc Surg; 2019 Aug; 158(2):442-450. PubMed ID: 30551960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic syndrome negatively impacts early patency of saphenous vein grafts.
    Yilmaz MB; Guray U; Guray Y; Biyikoglu SF; Tandogan I; Sasmaz H; Korkmaz S
    Coron Artery Dis; 2006 Feb; 17(1):41-4. PubMed ID: 16374140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radial artery versus saphenous vein patency randomized trial: five-year angiographic follow-up.
    Collins P; Webb CM; Chong CF; Moat NE;
    Circulation; 2008 Jun; 117(22):2859-64. PubMed ID: 18506009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative neutrophil-lymphocyte ratio and saphenous vein graft patency after coronary artery bypass grafting.
    Taşoğlu I; Turak O; Nazli Y; Ozcan F; Colak N; Sahin S; Kavasoglu K; Genc B; Sert D; Karahan M; Cicek O; Ecevit A
    Clin Appl Thromb Hemost; 2014 Nov; 20(8):819-24. PubMed ID: 23580624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serial angiographic follow-up of grafts one year and five years after coronary artery bypass surgery.
    Cho KR; Kim JS; Choi JS; Kim KB
    Eur J Cardiothorac Surg; 2006 Apr; 29(4):511-6. PubMed ID: 16439151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The no-touch saphenous vein as the preferred second conduit for coronary artery bypass grafting.
    Dreifaldt M; Mannion JD; Bodin L; Olsson H; Zagozdzon L; Souza D
    Ann Thorac Surg; 2013 Jul; 96(1):105-11. PubMed ID: 23684156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.